**To the Editor:** Histoplasmosis occurs after infection with the dimorphic fungus *Histoplasma capsulatum* ([@R1]*--*[@R6]). Patients become ill after they inhale soil contaminated with *H. capsulatum* ([@R1]*,*[@R2]). Most infections are asymptomatic or result in mild illness not determined to be histoplasmosis ([@R1]*,*[@R2]). Symptoms usually develop 3--14 days after exposure and range from self-limited pneumonia to severe disseminated disease requiring antifungal therapy ([@R2]*,*[@R7]).

In the United States, *H. capsulatum* is endemic to the Mississippi and Ohio River Valleys ([@R1]*,*[@R2]*,*[@R5]*,*[@R8]) but is not known to be endemic to the Rocky Mountain region ([@R8]). During June 2012--November 2013, a total of 6 unrelated cases of histoplasmosis were reported in Idaho (n = 1) and Montana (n = 5) in patients who had no recent travel to recognized *H. capsulatum*--endemic regions. Public health authorities investigated the illnesses by reviewing medical records and collecting exposure and travel histories.

The median age of the patients (3 male, 3 female) was 68 (range 17--79) years ([Table](#T1){ref-type="table"}). Each case was diagnosed by a different physician; no known epidemiologic links existed among the patients. Five patients had [\>]{.ul}1 immunocompromising conditions ([Table](#T1){ref-type="table"}), and 2 had acute pneumonia; 1 each had left parotid gland enlargement, anterior cervical lymphadenopathy, tricuspid valve mass, and acute changes in mental status. Three patients were hospitalized: 2 required intensive care, and 1 died.

###### Characteristics of 6 persons with histoplasmosis, Idaho and Montana, USA, 2012--2013\*

  Characteristic                                                             Value
  -------------------------------------------------------------------------- -------------
  Sex                                                                        
  M                                                                          3 (50)
  F                                                                          3 (50)
  Median age, y (range)                                                      68 (17--79)
  Location of residence                                                      
  Idaho, southwestern                                                        1 (17)
  Montana                                                                    
  Eastern                                                                    2 (33)
  Southwestern                                                               3 (50)
  Immunocompromising condition, n = 5†                                       
  Diabetes mellitus, type 2                                                  3 (50)
  Hepatitis C                                                                1 (17)
  Previous history of breast cancer                                          1 (17)
  Acute mononucleosis                                                        1 (17)
  Previous history of colon cancer                                           1 (17)
  Hospitalization                                                            3 (50)
  Death                                                                      1 (17)
  Tests with positive results that contributed to histoplasmosis diagnosis   
  Culture                                                                    2 (33)
  Histopathology‡                                                            2 (33)
  Urine enzyme immunoassay‡                                                  2 (33)
  Diagnosis delayed \>6 mo                                                   3 (50)
  At-risk activities                                                         
  Using potting soil containing bat guano                                    1 (17)
  Exploring caves                                                            1 (17)
  Mowing grass in pasture                                                    1 (17)
  Cleaning pigeon cages                                                      1 (17)
  Traveling to an area where the disease is endemic \<3 y of illness onset   0
  None known                                                                 2 (33)

\*Values are no. (%) patients except as indicated. †One patient had diabetes mellitus type 2 and hepatitis C; 1 patient had diabetes mellitus type 2 and a previous history of colon cancer. ‡One patient with a culture positive for *Histoplasma capsulatum* also had histopathology and urine enzyme immunoassay results consistent with *H. capsulatum* infection (results not shown).

Histoplasmosis was diagnosed primarily on the basis of culture (n = 2), urine enzyme immunoassay (EIA) (n = 2), and histopathologic examination (n = 2) results; histopathologic examinations were conducted by 2 pathologists ([Technical Appendix](#SD1){ref-type="local-data"} Table). One patient with *H. capsulatum*--positive cultures also had positive results by histopathology, serum antigen detection, and urine EIA. Another patient with positive urine EIA results for antigen detection also had low serum levels of *Histoplasma* antibodies measured by compliment fixation. No patient samples were tested by PCR.

The interval between a patient's initial visit to a health care provider and diagnosis ranged from 1 week to 20 months. Diagnosis was delayed \>6 months for 3 patients. For 2 patients, a diagnosis was made on the basis of an *H. capsulatum*--positive urine EIA result \<4 weeks from illness onset. Four (67%) patients underwent surgical procedures before histoplasmosis was diagnosed.

Each patient reported having traveled to *H. capsulatum*--endemic places, but none had traveled to these areas within 3 years of illness onset. Four patients reported exposures possibly related to infection (1 patient each): handling bat guano--containing potting soil manufactured in California, exploring caves, mowing pasture grass, and cleaning pigeon cages. The exposure to potting soil occurred in California; the other 3 exposures occurred in Montana. Two patients had no identifiable high-risk exposures to *H. capsulatum*.

These 6 patients with histoplasmosis represent potential acute infections and suggest that *H. capsulatum* might exist in Idaho and Montana, a geographic area farther west than areas where the fungus is known to be endemic. Areas of contaminated soils exist in microfoci outside recognized *H. capsulatum*--endemic areas and can be the source of infection for some persons ([@R6]). Previous studies suggest that the *H. capsulatum*--endemic area might extend into Montana and possibly other states in the Rocky Mountain region ([@R8]*--*[@R10]). Further environmental studies are needed to determine with certainty whether *H.* *capsulatum* fungi exist in natural environments in the Rocky Mountain region.

Delayed diagnosis of histoplasmosis increases the likelihood of delays in administering effective antifungal therapy. Histoplasmosis was diagnosed in 3 of these patients \>6 months after they first sought care, probably because they had reported no recent travel to *H. capsulatum*--endemic areas. Among these 3 patients, none had urine EIA testing for the presence of *H. capsulatum* antigen. The 2 patients who received a diagnosis of histoplasmosis \<4 weeks after they first sought care were assessed by using urine EIA. Urine EIA is a noninvasive and sensitive assay with high specificity but is subject to false-positive results in patients with other fungal infections, particularly blastomycosis ([@R6]), which is not known to be endemic in Montana or Idaho.

Investigation of these 6 histoplasmosis cases was limited because only 2 patients had cultures positive for *H. capsulatum,* and each patient had a remote travel history ([\>]{.ul}3 years before infection) to an *H. capsulatum*--endemic area. These limitations raise the possibility that the cases represent reactivation of latent disease or delayed clinical manifestations following a low-inoculum exposure years earlier in an area where the fungus is endemic ([@R2]*,*[@R6]). However, data supporting the possibility that reactivation of latent *H. capsulatum* infection causes acute illness are inconclusive ([@R6]).

In summary, health care providers should consider a diagnosis of histoplasmosis for Idaho and Montana residents having symptoms consistent with the disease, regardless of whether they have a travel history to recognized *H. capsulatum*--endemic areas. When considering a diagnosis of histoplasmosis, providers should also consider testing with urine EIA, a noninvasive way to assess the presence of *H. capsulatum* infection.

###### 

**Technical Appendix.** Laboratory findings in histoplasmosis patients, Idaho and Montana, USA, 2012--2013.
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